ATAI Life Sciences N.V. (NASDAQ: ATAI) is 20.57% higher on its value in year-to-date trading and has touched a low of $1.02 and a high of $2.39 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The ATAI stock was last observed hovering at around $1.67 in the last trading session, with the day’s gains setting it 0.03%.
Currently trading at $1.70, the stock is -11.48% and -9.13% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.61 million and changing 1.80% at the moment leaves the stock 6.01% off its SMA200. ATAI registered 42.86% gain for a year compared to 6-month gain of 20.57%. The firm has a 50-day simple moving average (SMA 50) of $264.17 and a 200-day simple moving average (SMA200) of -$1.31.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -15.42% loss in the last 1 month and extending the period to 3 months gives it a 25.00%, and is -7.61% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 8.83% over the week and 8.60% over the month.
ATAI Life Sciences N.V. (ATAI) has around 119 employees, a market worth around $282.22M and $0.33M in sales. Distance from 52-week low is 65.85% and -28.87% from its 52-week high. The company has generated returns on investments over the last 12 months (-23.68%).
ATAI Life Sciences N.V. quarterly earnings per share for the current quarter are estimated at -$0.16 with sales reaching $190k over the same period.The EPS is expected to grow by 67.81% this year, but quarterly earnings will post 93.10% year-over-year. Quarterly sales are estimated to grow 400.00% in year-over-year returns.
109 institutions hold shares in ATAI Life Sciences N.V. (ATAI), with institutional investors hold 31.15% of the company’s shares. The shares outstanding are 165.94M, and float is at 115.35M with Short Float at 3.06%. Institutions hold 28.02% of the Float.
The top institutional shareholder in the company is Blackrock Inc. with over 2.46 million shares valued at $4.23 million. The investor’s holdings represent 1.48% of the ATAI Shares outstanding. As of Jun 29, 2023, the second largest holder is Morgan Stanley with 2.11 million shares valued at $3.64 million to account for 1.27% of the shares outstanding. The other top investors are Millennium Management Llc which holds 1.11 million shares representing 0.67% and valued at over $1.91 million, while Cerity Partners LLC holds 0.56% of the shares totaling 0.92 million with a market value of $1.59 million.
ATAI Life Sciences N.V. (ATAI) Insider Activity
The most recent transaction is an insider purchase by Brand Florian, the company’s . SEC filings show that Brand Florian bought 20,000 shares of the company’s common stock on Nov 16 ’23 at a price of $1.16 per share for a total of $23120.0. Following the purchase, the insider now owns 0.13 million shares.
ATAI Life Sciences N.V. disclosed in a document filed with the SEC on Sep 13 ’23 that Brand Florian () bought a total of 40,000 shares of the company’s common stock. The trade occurred on Sep 13 ’23 and was made at $1.45 per share for $57968.0. Following the transaction, the insider now directly holds 0.11 million shares of the ATAI stock.
Still, SEC filings show that on Mar 29 ’23, Apeiron Investment Group Ltd. (10% Owner) acquired 1,214,297 shares at an average price of $1.32 for $1.6 million. The insider now directly holds 32,086,697 shares of ATAI Life Sciences N.V. (ATAI).
